MindWalk Holdings (HYFT) Income from Non-Controlling Interests (2020 - 2022)
Powered by 
Analysis
MindWalk Holdings (HYFT) Income from Non-Controlling Interests (2020 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.21 Bn | 132.36 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.73 Bn | 58.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.59 Bn | 52.46 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 40.13 Bn | 35.04 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.55 Bn | 32.24 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.60 Bn | 27.77 Bn | - | 63.60 Mn |
| 9 | Insmed | 27.70 Bn | 26.54 Bn | 358.27 Mn | - |
| 10 | MindWalk Holdings | 61.22 Mn | 52.95 Mn | 1.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2022 | 867,720.27 |
| Apr 30, 2022 | 620,590.34 |
| Jan 31, 2022 | 673,149.55 |
| Oct 31, 2021 | 548,056.63 |
| Jul 31, 2021 | 1.15 Mn |
| Apr 30, 2021 | 1.05 Mn |
| Jan 31, 2021 | 662,710.55 |
| Oct 31, 2020 | 360,444.65 |
| Apr 30, 2020 | 69,712.13 |
| Jan 31, 2020 | 108,755.34 |